ORAMED PHARMACEUTICALS INC (ORMP) Stock Analyst Ratings
NASDAQ:ORMP • US68403P2039
3.73 USD
+0.27 (+7.8%)
At close: Feb 25, 2026
3.62 USD
-0.11 (-2.95%)
Pre-Market: 2/26/2026, 8:00:04 AM
ChartMill assigns a Buy % Consensus number of 43% to ORMP. The Buy consensus is the weighted average rating of the current analysts ratings.
- ORMP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ORMP.
- In the previous month the buy percentage consensus was at a similar level.
- ORMP was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-20 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-05-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-01-17 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-01-12 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-05-16 | Aegis Capital | Maintains | Buy |
| 2022-02-18 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-11-30 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-29 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-02 | Aegis Capital | Maintains | Buy |
| 2021-07-29 | Canaccord Genuity | Maintains | Buy |
| 2021-06-08 | Aegis Capital | Maintains | Buy |
| 2021-04-20 | Canaccord Genuity | Initiate | Buy |
| 2021-02-09 | National Securities Corporation | Initiate | Buy |
ORAMED PHARMACEUTICALS INC / ORMP FAQ
Can you provide the consensus rating for ORAMED PHARMACEUTICALS INC stock?
The consensus rating for ORAMED PHARMACEUTICALS INC (ORMP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover ORAMED PHARMACEUTICALS INC (ORMP) stock?
The number of analysts covering ORAMED PHARMACEUTICALS INC (ORMP) is 6.